AduaE, RussellA, RobertsP, WangY, SongM, and WangW. (2017). Innovation analysis on postgenomic biomarkers: Glycomics for chronic diseases. OMICS, 21, 183–196.
2.
GeSQ, WangY, SongM, et al. (2018). Type 2 diabetes mellitus: Integrative analysis of multiomics data for biomarker discovery. OMICS, 22, 514–523
3.
LiuD, ChuX, WangH, et al. (2018a). The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia. J Transl Med, 16, 1–10.
4.
LiuJN, DolikunM, ŠtambukJ, et al. (2018b). The association between subclass-specific IgG Fc N-glycosylation profiles and hypertension in the Uygur, Kazak, Kirgiz, and Tajik populations. J Hum Hypertens, 32, 555.
5.
LiuD, ZhaoZ, WangA, et al. (2018c). Ischemic stroke is associated with the pro-inflammatory potential of N-glycosylated immunoglobulin G. J Neuroinflammation, 15, 1–10.
6.
LuJ, KneževićA, WangYX, et al. (2011). Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations. J Proteome Res, 1011, 4959–4969
7.
MaQ, AduaE, BoyceM, LiX, JiG, and WangW. (2018). IMass time: The future, in future!. OMICS, 22, 679–695.
8.
RussellA, ŠimurinaM, GarciaMT, et al. (2017). The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease. Glycobiology, 27, 501–510
9.
SebastianA, AlzainMA, AswetoCO, et al. (2016). Glycan biomarkers for rheumatoid arthritis and its remission status in Han Chinese patients. OMICS, 20, 343–351.
10.
VučkovićF, KrištićJ, GudeljI, et al. (2015). Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG flycome. Arthritis Rheumatol, 67, 2978–2989.
11.
WangW. (2013). Validation and development of N-glycan as biomarker in cancer diagnosis. Curr Pharmacogenomics Person Med, 11, 53–58.
12.
WangW, and JiaJT. (1987). Phenotyping of phosphoglucomutase (PGM1) subtypes in Chinese, with special reference to new variant PGM1 China. Med Sci Law, 27, 280–282.
13.
WangY, AduaE, RussellA, et al. (2016). Glycomics and its application potential in precision medicine in China. Science/AAAS 354, DC, 36–39.
14.
YuX, WangY, KristicJ, et al. (2016). Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese population. Medicine, 95, e4112.
